speb/financial-data huggingface dataset:
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 285471000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Change In Inventory: 323543000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Change In Payable: 270391000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -547310000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: 46624000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -69768000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Common Stock: 274973000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 274973000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 8518833000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 8518833000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 1513892000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 1513892000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 3084180000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1361151000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Current Assets: 7333382000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 7333382000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 13260000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 13260000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Current Debt: 4206894000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 4206894000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 4220154000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 4220154000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Current Deferred Taxes Liabilities: 45498000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Current Deferred Taxes Liabilities: 45498000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 8976454000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 8976454000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 411838000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 411838000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Depreciation: 786370000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 786370000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 786370000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 213212000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 786370000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 213212000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 27494265.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 27493821.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Diluted EPS: 16.39
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 6.15
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 450631000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 169087000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 1674000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 1674000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — EBIT: 1394151000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — EBIT: 461305000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — EBITDA: 2180521000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — EBITDA: 674517000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — End Cash Position: 285471000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -626142000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 698045000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 698045000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 622273000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -74600000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 36005000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 100415000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 130000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 130000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 426466000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 426466000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 18661869000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 18661869000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Gross Profit: 13725698000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 3667813000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Impairment Of Capital Assets: -45518000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Interest Expense: 694261000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 191655000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 694261000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 191655000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Interest Income: 116991000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 116991000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -664780000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 90655000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Inventory: 2752450000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 2752450000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 14668042000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 14668042000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -1319966000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 28255000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 28255000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 528094000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 1314801000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 1314801000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 110714000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 110714000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 1942315000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 1942315000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 2053029000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 2053029000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 528094000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -1216534000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 143208000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 143208000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 12945574000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 12945574000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Net Debt: 5863738000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 5863738000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Net Income: 450631000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Net Income: 169087000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 450631000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 169087000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 450631000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 169087000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 450631000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 169087000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 450631000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 169087000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 699890000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 450631000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 169087000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Net Interest Income: -694261000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -191655000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -266563000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 127999000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -688440000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -694261000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -191655000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Net PPE: 13288440000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 13288440000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -1144058000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 816439000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 8518703000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 8518703000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 764408000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 764408000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 982219000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 982219000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 219253000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 219253000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 786084000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 786084000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 2180521000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 674517000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Normalized Income: 450631000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 169087000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 1876340000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Operating Income: 787913000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Operating Income: 328294000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Operating Revenue: 16809878000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 5028964000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 27497298.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 27497298.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 1474793000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 1474793000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 751063000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 751063000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 8243859000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 8243859000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 130000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 130000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Other Inventories: 700000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: 700000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 535196000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: -1000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: -1000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: -1000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: -1000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 606238000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 133011000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 6994178000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 1638030000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Other Payable: 395354000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 395354000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Other Properties: 11689392000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 11689392000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 73343000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 73343000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 1669904000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 1669904000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Other Special Charges: 36005000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Payables: 2960253000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Payables: 2960253000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 239133000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 239133000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 1419449000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 1419449000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Pretax Income: 699890000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 269650000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Properties: 135209000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Properties: 135209000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 693000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -667144000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -1254067000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 1168715000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 1168715000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 3084180000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1361151000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 786370000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 213212000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 49680000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 49680000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -1216534000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 604226000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 604226000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 7389071000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 7389071000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 400581000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 110009000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 3833204000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 1163056000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 3833204000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1163056000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Share Issued: 27497298.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 27497298.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 8518833000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 8518833000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 8518703000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 8518703000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Tax Provision: 249259000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 100563000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.36
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.37
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 131343000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 131343000.00
MANGLMCEM.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -139024000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Total Assets: 21662273000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 21662273000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 10461148000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 10461148000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Total Debt: 6273183000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 6273183000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 8518833000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 8518833000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Total Expenses: 16021965000.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 4700670000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 13143440000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 13143440000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 14328891000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 14328891000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 4166986000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 4166986000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 251272000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 45498000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 45498000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
MANGLMCEM.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Tradeand Other Payables Non Current: 4870000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 4870000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Work In Process: 884990000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 884990000.00
MANGLMCEM.NS balance_sheet (annual, 2025-03-31) — Working Capital: -1643072000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: -1643072000.00
MANGLMCEM.NS income_statement (annual, 2025-03-31) — Write Off: 14799000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 3467283000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 4517426000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 27501535.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 11.73
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 499857000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 201523000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 201523000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 27501535.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 11.73
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 322593000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — EBIT: 656521000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — EBITDA: 858044000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 4017569000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 165090000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 165090000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Net Income: 322593000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 322593000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 322593000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 322593000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 322593000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 322593000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -165090000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -165090000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 858044000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 322593000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Operating Income: 550286000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 4517426000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 106235000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 1833804000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 491431000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 499857000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 201523000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 1057771000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1057771000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 168838000.00
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.34
MANGLMCEM.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 3967140000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 3325547000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 3948757000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 2736421000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 370035000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 409505000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 27503830.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 7.31
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 201602000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 274973000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 58609000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 2176974000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 274973000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 9002702000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 1095845000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 398532000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 7889665000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 26740000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 4815083000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 4841823000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 9824631000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 234078000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 202308000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 202308000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 27503830.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 7.31
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 201053000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — EBIT: 322184000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — EBITDA: 524492000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 83292000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 12559516000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 3550225000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 157800000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 157800000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 3651860000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 16142247000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 409505000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 174862000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 2324462000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 2499324000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 396076000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 7080936000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Net Income: 201053000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 201053000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 201053000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 201053000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 201053000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 201053000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -157800000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -157800000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 12559516000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 8919410000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 1000590000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 524492000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 201053000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Operating Income: 224678000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 3948757000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 27497298.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 1690796000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 1261446000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 8727729000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 83292000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 2470153000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 246537000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 97506000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 1877795000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 11463671000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 2118365000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Payables: 2858480000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 164384000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 398532000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 202308000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 897700000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Selling General And Administration: 897700000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 27497298.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 9002702000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 8919410000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Tax Provision: -36669000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.30
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 0.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 23502611000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 11327164000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 7341147000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 9002702000.00
MANGLMCEM.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 3724079000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 14499909000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 15612946000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 4675278000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 122059000.00
MANGLMCEM.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: -1934966000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 3323491000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 4213868000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 27484504.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 4.13
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 644310000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 204039000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 204039000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 27484504.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 4.13
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 113511000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — EBIT: 309055000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — EBITDA: 513094000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 3569558000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 153413000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 153413000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Net Income: 113511000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 113511000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 113511000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 113511000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 113511000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 113511000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -153413000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -153413000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 523387000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 121017770.17
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Operating Income: 246067000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 4213868000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 73281000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 1826356000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 155642000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 644310000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 204039000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 962771000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Selling General And Administration: 962771000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -10293000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -2786229.83
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 42131000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.27
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 3967801000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -10293000.00
MANGLMCEM.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -10293000.00
MANGLMCEM.NS income_statement (annual, 2026-03-31) — +Operating Expense: 13498726000.00
MANGLMCEM.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 3382405000.00
MANGLMCEM.NS income_statement (annual, 2026-03-31) — +Total Revenue: 17584061000.00
MANGLMCEM.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 4904010000.00
MANGLMCEM.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 2020299000.00
MANGLMCEM.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 2020299000.00
MANGLMCEM.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 374494000.00
MANGLMCEM.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 374494000.00
MANGLMCEM.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 300975000.00
MANGLMCEM.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 300975000.00
MANGLMCEM.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 27501939.00
MANGLMCEM.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 23.72
MANGLMCEM.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 285471000.00
MANGLMCEM.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -3481994000.00
MANGLMCEM.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 189135000.00
MANGLMCEM.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 189135000.00
MANGLMCEM.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 274973000.00
MANGLMCEM.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 274973000.00
MANGLMCEM.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 82694000.00
MANGLMCEM.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 82694000.00
MANGLMCEM.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2380922000.00
MANGLMCEM.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2380922000.00
MANGLMCEM.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -41246000.00
MANGLMCEM.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -434218000.00
MANGLMCEM.NS cash_flow (annual, 2026-03-31) — Change In Payable: -774475000.00
MANGLMCEM.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -151313000.00
MANGLMCEM.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -1360006000.00
MANGLMCEM.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -202777000.00
MANGLMCEM.NS balance_sheet (annual, 2026-03-31) — Common Stock: 274973000.00
MANGLMCEM.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 274973000.00
MANGLMCEM.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 9772923000.00
MANGLMCEM.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 9772923000.00
MANGLMCEM.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 535096000.00
MANGLMCEM.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 535096000.00
MANGLMCEM.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 2725175000.00
MANGLMCEM.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1182476000.00
MANGLMCEM.NS balance_sheet (annual, 2026-03-31) — Current Assets: 7159433000.00
MANGLMCEM.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 7159433000.00
MANGLMCEM.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 29153000.00
MANGLMCEM.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 29153000.00
MANGLMCEM.NS balance_sheet (annual, 2026-03-31) — Current Debt: 5943236000.00
MANGLMCEM.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 5943236000.00
MANGLMCEM.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 5972389000.00
MANGLMCEM.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 5972389000.00
MANGLMCEM.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 9910210000.00
MANGLMCEM.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 9910210000.00
MANGLMCEM.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 80214000.00
MANGLMCEM.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 80214000.00
MANGLMCEM.NS cash_flow (annual, 2026-03-31) — Depreciation: 808510000.00
MANGLMCEM.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 808510000.00
MANGLMCEM.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 808510000.00
MANGLMCEM.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 200640000.00
MANGLMCEM.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 808510000.00
MANGLMCEM.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 200640000.00
MANGLMCEM.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 27501939.00
MANGLMCEM.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 23.72
MANGLMCEM.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 1289503000.00
MANGLMCEM.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 652346000.00
MANGLMCEM.NS income_statement (annual, 2026-03-31) — EBIT: 1582320000.00
MANGLMCEM.NS income_statement (quarterly, 2026-03-31) — EBIT: 294560000.00
MANGLMCEM.NS income_statement (annual, 2026-03-31) — EBITDA: 2390830000.00
MANGLMCEM.NS income_statement (quarterly, 2026-03-31) — EBITDA: 495200000.00
MANGLMCEM.NS cash_flow (annual, 2026-03-31) — End Cash Position: 82694000.00
MANGLMCEM.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 1827686000.00
MANGLMCEM.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -2542312000.00
MANGLMCEM.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -95624000.00
MANGLMCEM.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 38783000.00
MANGLMCEM.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 89954000.00
MANGLMCEM.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 89954000.00
MANGLMCEM.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 13396606000.00
MANGLMCEM.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 13396606000.00
MANGLMCEM.NS income_statement (annual, 2026-03-31) — Gross Profit: 14858886000.00
MANGLMCEM.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 3721534000.00
MANGLMCEM.NS income_statement (annual, 2026-03-31) — Interest Expense: 640425000.00
MANGLMCEM.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 164122000.00
MANGLMCEM.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 640425000.00
MANGLMCEM.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 164122000.00
MANGLMCEM.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -546503000.00
MANGLMCEM.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 124677000.00
MANGLMCEM.NS balance_sheet (annual, 2026-03-31) — Inventory: 3186668000.00
MANGLMCEM.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 3186668000.00
MANGLMCEM.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 18468707000.00
MANGLMCEM.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 18468707000.00
MANGLMCEM.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -2970145000.00
MANGLMCEM.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 300975000.00
MANGLMCEM.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 300975000.00
MANGLMCEM.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 1561102000.00
MANGLMCEM.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 159982000.00
MANGLMCEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 159982000.00
MANGLMCEM.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 2752548000.00
MANGLMCEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 2752548000.00
MANGLMCEM.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 2912530000.00
MANGLMCEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 2912530000.00
MANGLMCEM.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 1561102000.00
MANGLMCEM.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -744713000.00
MANGLMCEM.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 385809000.00
MANGLMCEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 385809000.00
MANGLMCEM.NS balance_sheet (annual, 2026-03-31) — Net Debt: 8613090000.00
MANGLMCEM.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 8613090000.00
MANGLMCEM.NS income_statement (annual, 2026-03-31) — Net Income: 1289503000.00
MANGLMCEM.NS income_statement (quarterly, 2026-03-31) — Net Income: 652346000.00
MANGLMCEM.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 1289503000.00
MANGLMCEM.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 652346000.00
MANGLMCEM.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 1289503000.00
MANGLMCEM.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 652346000.00
MANGLMCEM.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1289503000.00
MANGLMCEM.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 652346000.00
MANGLMCEM.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1289503000.00
MANGLMCEM.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 652346000.00
MANGLMCEM.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 941895000.00
MANGLMCEM.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 1289503000.00
MANGLMCEM.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 652346000.00
MANGLMCEM.NS income_statement (annual, 2026-03-31) — Net Interest Income: -640425000.00
MANGLMCEM.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -164122000.00
MANGLMCEM.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 81261000.00
MANGLMCEM.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 2455250000.00
MANGLMCEM.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 816389000.00
MANGLMCEM.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -640425000.00